1 | up | 29,717 |
2 | v3r | 9 |
3 | -up | 7 |
4 | g-/gm-csf | 6 |
5 | monoresistance | 6 |
6 | ma-a27 | 4 |
7 | up.the | 4 |
8 | 'air | 2 |
9 | 'where | 2 |
10 | 15gy | 2 |
11 | 27°s | 2 |
12 | 4.0- | 2 |
13 | araneomorphae | 2 |
14 | cepdin | 2 |
15 | cu2cd1-xmnxsnse4 | 2 |
16 | igf-1-rs1520220 | 2 |
17 | pelletizing | 2 |
18 | te/ate | 2 |
19 | 11,001 | 1 |
20 | 2,5-diketo-3-deoxygluconate | 1 |
21 | 2-24h | 1 |
22 | 20,505 | 1 |
23 | 20-21m/min | 1 |
24 | 327,698 | 1 |
25 | 34713 | 1 |
26 | 6,233 | 1 |
27 | 81/114 | 1 |
28 | additions/enhancements | 1 |
29 | adults.how | 1 |
30 | affirmately | 1 |
31 | byjanajati | 1 |
32 | chloroboranes | 1 |
33 | dihydroxyacetone-phosphate | 1 |
34 | disproportions | 1 |
35 | eligibility/deferral | 1 |
36 | explcit | 1 |
37 | extraclinically | 1 |
38 | from14.7 | 1 |
39 | hyporesponsivity | 1 |
40 | lf-diets | 1 |
41 | m+r+c | 1 |
42 | multi-databases | 1 |
43 | mwms | 1 |
44 | nonprogrammers | 1 |
45 | phosforylated | 1 |
46 | practicedue | 1 |
47 | pre-adolescent/adolescent | 1 |
48 | protocol-i | 1 |
49 | psychoeducators | 1 |
50 | radiocolloids | 1 |
51 | resistance/intolerance | 1 |
52 | ring-by-ring | 1 |
53 | rr=0.615 | 1 |
54 | rubbing/massage | 1 |
55 | spidersilk | 1 |
56 | symptom-changes | 1 |
57 | time/risk | 1 |
58 | up-examinations | 1 |
59 | up-interviews | 1 |
60 | up.for | 1 |
61 | up.studies | 1 |
62 | up.we | 1 |
63 | venereologists | 1 |
64 | walking/bicycling | 1 |
1 | 'air | 2 |
2 | 'where | 2 |
3 | -up | 7 |
4 | 11,001 | 1 |
5 | 15gy | 2 |
6 | 2,5-diketo-3-deoxygluconate | 1 |
7 | 2-24h | 1 |
8 | 20,505 | 1 |
9 | 20-21m/min | 1 |
10 | 27°s | 2 |
11 | 327,698 | 1 |
12 | 34713 | 1 |
13 | 4.0- | 2 |
14 | 6,233 | 1 |
15 | 81/114 | 1 |
16 | additions/enhancements | 1 |
17 | adults.how | 1 |
18 | affirmately | 1 |
19 | araneomorphae | 2 |
20 | byjanajati | 1 |
21 | cepdin | 2 |
22 | chloroboranes | 1 |
23 | cu2cd1-xmnxsnse4 | 2 |
24 | dihydroxyacetone-phosphate | 1 |
25 | disproportions | 1 |
26 | eligibility/deferral | 1 |
27 | explcit | 1 |
28 | extraclinically | 1 |
29 | from14.7 | 1 |
30 | g-/gm-csf | 6 |
31 | hyporesponsivity | 1 |
32 | igf-1-rs1520220 | 2 |
33 | lf-diets | 1 |
34 | m+r+c | 1 |
35 | ma-a27 | 4 |
36 | monoresistance | 6 |
37 | multi-databases | 1 |
38 | mwms | 1 |
39 | nonprogrammers | 1 |
40 | pelletizing | 2 |
41 | phosforylated | 1 |
42 | practicedue | 1 |
43 | pre-adolescent/adolescent | 1 |
44 | protocol-i | 1 |
45 | psychoeducators | 1 |
46 | radiocolloids | 1 |
47 | resistance/intolerance | 1 |
48 | ring-by-ring | 1 |
49 | rr=0.615 | 1 |
50 | rubbing/massage | 1 |
51 | spidersilk | 1 |
52 | symptom-changes | 1 |
53 | te/ate | 2 |
54 | time/risk | 1 |
55 | up | 29,717 |
56 | up-examinations | 1 |
57 | up-interviews | 1 |
58 | up.for | 1 |
59 | up.studies | 1 |
60 | up.the | 4 |
61 | up.we | 1 |
62 | v3r | 9 |
63 | venereologists | 1 |
64 | walking/bicycling | 1 |
1 | 4.0- | 2 |
2 | igf-1-rs1520220 | 2 |
3 | 11,001 | 1 |
4 | 34713 | 1 |
5 | 6,233 | 1 |
6 | 81/114 | 1 |
7 | cu2cd1-xmnxsnse4 | 2 |
8 | 20,505 | 1 |
9 | rr=0.615 | 1 |
10 | from14.7 | 1 |
11 | ma-a27 | 4 |
12 | 327,698 | 1 |
13 | m+r+c | 1 |
14 | phosforylated | 1 |
15 | araneomorphae | 2 |
16 | resistance/intolerance | 1 |
17 | monoresistance | 6 |
18 | rubbing/massage | 1 |
19 | up.the | 4 |
20 | 'where | 2 |
21 | te/ate | 2 |
22 | dihydroxyacetone-phosphate | 1 |
23 | 2,5-diketo-3-deoxygluconate | 1 |
24 | practicedue | 1 |
25 | up.we | 1 |
26 | g-/gm-csf | 6 |
27 | walking/bicycling | 1 |
28 | ring-by-ring | 1 |
29 | pelletizing | 2 |
30 | 2-24h | 1 |
31 | protocol-i | 1 |
32 | byjanajati | 1 |
33 | spidersilk | 1 |
34 | time/risk | 1 |
35 | eligibility/deferral | 1 |
36 | cepdin | 2 |
37 | 20-21m/min | 1 |
38 | up | 29,717 |
39 | -up | 7 |
40 | v3r | 9 |
41 | 'air | 2 |
42 | up.for | 1 |
43 | radiocolloids | 1 |
44 | symptom-changes | 1 |
45 | up.studies | 1 |
46 | chloroboranes | 1 |
47 | multi-databases | 1 |
48 | mwms | 1 |
49 | up-examinations | 1 |
50 | disproportions | 1 |
51 | nonprogrammers | 1 |
52 | psychoeducators | 1 |
53 | lf-diets | 1 |
54 | additions/enhancements | 1 |
55 | venereologists | 1 |
56 | up-interviews | 1 |
57 | 27°s | 2 |
58 | explcit | 1 |
59 | pre-adolescent/adolescent | 1 |
60 | adults.how | 1 |
61 | 15gy | 2 |
62 | affirmately | 1 |
63 | extraclinically | 1 |
64 | hyporesponsivity | 1 |